Post-earnings recap
Reported
Fri, Jan 9, 2026
EPS actual
$-0.02
EPS est.
—
EPS surprise
—
1-day move
-2.84%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CytoDyn Inc. reported a loss per share of $-0.02, but did not provide revenue figures or future guidance. The stock reacted negatively, declining by 2.84% following the earnings announcement, indicating investor uncertainty about the company's performance and outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.02 | N/A | — |
| Revenue | — | N/A | — |
No transcript is on record, and the analysis is based on numerical results only.